Abstract
G protein-coupled receptors (GPCRs) comprise the main signal-transmitting components in the cell membrane. Over the past several years, biochemical and structural analyses have immensely enhanced our knowledge of GPCR involvement in health and disease states. The present review focuses on GPCRs that are cancer drivers, involved in tumor growth and development. Our aim is to highlight the involvement of stabilized β-catenin molecular machinery with a specific array of GPCRs. We discuss recent advances in understanding the molecular path leading to β-catenin nuclear localization and transcriptional activity and their implications for future cancer therapy research.
| Original language | English |
|---|---|
| Pages (from-to) | 147-157 |
| Number of pages | 11 |
| Journal | Cancer and Metastasis Reviews |
| Volume | 37 |
| Issue number | 1 |
| DOIs | |
| State | Published - 1 Mar 2018 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2017, Springer Science+Business Media, LLC, part of Springer Nature.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cancer
- G protein-coupled receptors
- β-catenin
Fingerprint
Dive into the research topics of 'Cancer driver G-protein coupled receptor (GPCR) induced β-catenin nuclear localization: the transcriptional junction'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver